Answers are grounded in this paper and cite their sources.
TD-1792 is a multivalent glycopeptide-cephalosporin heterodimer antibiotic with potent activity against Gram-positive bacteria. We tested TD-1792 against 377 anaerobes and 34 strains of Corynebacterium species. Against nearly all Gram-positive strains, TD-1792 had an MIC₉₀ of 0.25 μg/ml and was typically 3 to 7 dilutions more active than vancomycin and daptomycin.
No takes yet. Share an insight, caveat, or question.
Tyrrell et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: